Meredith S. Duncan

Meredith S. Duncan

Auto-generated profile, based on publicly available information

Meredith S. Duncan

Department of Biostatistics, University of Kentucky, Lexington, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2021 in JAMA Cardiology
Verified
Journal Article
Open access
PDF file
MDMeredith S. Duncan
Meredith S. Duncan
RGRobert A. Greevy
Robert A. Greevy
HTHilary A. Tindle
Hilary A. Tindle
RVRamachandran S. Vasan
Ramachandran S. Vasan
LLLoren Lipworth
Loren Lipworth
MFMatthew S. Freiberg
Matthew S. Freiberg
The cornerstone of atherosclerotic cardiovascular disease (ASCVD) prevention is assessing risk prior to an event and implementing lifestyle and drug interventions accordingly; the current criterion standard risk assessment tool is the ASCVD Risk Estimator Plus.1,2 This calculator considers former smokers, for the first 5 years after cessation, to be at excess ASCVD risk compared with never smokers and does not incorporate pack-years smoked. However, we recently demonstrated that excess ASCVD risk among former heavy (≥20 pack-years) smokers vs never smokers can remain for up to 16 years postcessation.3 Thus, years since quitting (YSQ) and pack-years smoked may play an important role in ASCVD risk estimation.

1 January 2020 in Journal of Lipid and Atherosclerosis
Verified
Journal Article
Open access
PDF file
SCSharon Cresci
Sharon Cresci
RZRuibo Zhang
Ruibo Zhang
QYQiong Yang
Qiong Yang
MDMeredith S. Duncan
Meredith S. Duncan
VXVanessa Xanthakis
Vanessa Xanthakis
LPLinda Peterson
Linda Peterson
Cresci S, et al. J Lipid Atheroscler. 2020 Jan;9(1):172-183. https://doi.org/10.12997/jla.2020.9.1.172

21 September 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
MFMatthew S. Freiberg
Matthew S. Freiberg
MDMeredith S. Duncan
Meredith S. Duncan
CACharles Alcorn
Charles Alcorn
CCChung‐Chou H. Chang
Chung‐Chou H. Chang
SKSuman Kundu
Suman Kundu
ZTZian H. Tseng
Zian H. Tseng
Background: People living with HIV have higher sudden cardiac death (SCD) rates compared with the general population. Whether HIV infection is an independent SCD risk factor is unclear. Methods and Results: This study evaluated participants from the Veterans Aging Cohort Study, an observational, longitudinal cohort of veterans with and without HIV infection matched 1:2 on age, sex, race/ethnicity, and clinical site. Baseline for this study was a participant's first clinical visit on or after April 1, 2003. Participants were followed through December 31, 2014. Using Cox proportional hazards regression, we assessed whether HIV infection, CD4 cell counts, and/or HIV viral load were associated with World Health Organization (WHO)–defined SCD risk. Among 144 336 participants (30% people living with HIV), the mean (SD) baseline age was 50.0 years (10.6 years), 97% were men, and 47% were of Black race. During follow‐up (median, 9.0 years), 3035 SCDs occurred. HIV infection was associated with increased SCD risk (hazard ratio [HR], 1.14; 95% CI, 1.04–1.25), adjusting for possible confounders. In analyses with time‐varying CD4 and HIV viral load, people living with HIV with CD4 counts 500 copies/mL (HR, 1.70; 95% CI, 1.46–1.98) had increased SCD risk versus veterans without HIV. In contrast, people living with HIV who had CD4 cell counts >500 cells/mm 3 (HR, 1.03; 95% CI, 0.90–1.18) or HIV viral load <500 copies/mL (HR, 0.97; 95% CI, 0.87–1.09) were not at increased SCD risk. Conclusions: HIV infection is associated with increased risk of WHO‐defined SCD among those with elevated HIV viral load or low CD4 cell counts.

1 July 2021 in The Lancet Healthy Longevity
Verified
Journal Article
Open access
MDMeredith S Duncan
Meredith S Duncan
CACharles W Alcorn
Charles W Alcorn
MFMatthew S Freiberg
Matthew S Freiberg
KSKaku So-Armah
Kaku So-Armah
OPOlga V Patterson
Olga V Patterson
EBEvan L Brittain
Evan L Brittain
Pulmonary hypertension incidence based on echocardiographic estimates of pulmonary artery systolic pressure in people living with HIV remains unstudied. We aimed to determine whether people living with HIV have higher incidence and risk of pulmonary hypertension than uninfected individuals. In this retrospective cohort study, we evaluated data from participants in the Veterans Aging Cohort Study (VACS) referred for echocardiography with baseline pulmonary artery systolic pressure measures of 35 mm Hg or less. Incident pulmonary hypertension was defined as pulmonary artery systolic pressure higher than 35 mm Hg on subsequent echocardiogram. We used Poisson regression to estimate incidence rates (IRs) of pulmonary hypertension by HIV status. We then estimated hazard ratios (HRs) by HIV status using Cox proportional hazards regression. We further categorised veterans with HIV by CD4 count or HIV viral load to assess the association between pulmonary hypertension risk and HIV severity. Models included age, sex, race or ethnicity, prevalent heart failure, chronic obstructive pulmonary disease, hypertension, smoking status, diabetes, body-mass index, estimated glomerular filtration rate, hepatitis C virus infection, liver cirrhosis, and drug use as covariates. Of 21 314 VACS participants with at least one measured PASP on or after April 1, 2003, 13 028 VACS participants were included in the analytic sample (4174 [32%] with HIV and 8854 [68%] without HIV). Median age was 58 years and 12 657 (97%) were male. Median follow-up time was 3·1 years (IQR 0·9–6·8) spanning from April 1, 2003, to Sept 30, 2017. Unadjusted IRs per 1000 person-years were higher in veterans with HIV (IR 28·6 [95% CI 26·1–31·3]) than in veterans without HIV (IR 23·4 [21·9–24·9]; p=0·0004). The risk of incident pulmonary hypertension was higher among veterans with HIV than among veterans without HIV (unadjusted HR 1·25 [95% CI 1·12–1·40], p<0·0001). After multivariable adjustment, this association was slightly attenuated but remained significant (HR 1·18 [1·05–1·34], p=0·0062). Veterans with HIV who had a CD4 count lower than 200 cells per μL or of 200–499 cells per μL had a higher risk of pulmonary hypertension than did veterans without HIV (HR 1·94 [1·49–2·54], p<0·0001, for those with <200 cell μL and HR 1·29 [1·08–1·53], p=0·0048, for those with 200–499 cells per μL). Similarly, veterans with HIV who had HIV viral loads of 500 copies per mL or more had a higher risk of pulmonary hypertension than did veterans without HIV (HR 1·88 [1·46–2·42], p<0·0001). HIV is associated with pulmonary hypertension incidence, adjusting for risk factors. Low CD4 cell count and high HIV viral load contribute to increased pulmonary hypertension risk among veterans with HIV. Thus, as with other cardiopulmonary diseases, suppression of HIV should be prioritised to lessen the burden of pulmonary hypertension in people living with HIV. National Heart, Lung, and Blood Institute (National Institutes of Health, USA); National Institute on Alcohol Abuse and Alcoholism (National Institutes of Health, USA).

3 November 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
AAAaron W. Aday
Aaron W. Aday
MDMeredith S. Duncan
Meredith S. Duncan
OPOlga V. Patterson
Olga V. Patterson
SDScott L. DuVall
Scott L. DuVall
PAPatrick Raymond Alba
Patrick Raymond Alba
MFMatthew S. Freiberg
Matthew S. Freiberg
Lower-extremity peripheral artery disease (PAD) is common and occurs among 200 million individuals worldwide.1 Patients with PAD are at increased risk of cardiac, cerebrovascular, and limb-related morbidity and mortality.2 Traditional cardiovascular risk factors, including older age,3 smoking,4,5 and diabetes,6,7 are also associated with increased risk of incident PAD.

15 June 2022 in Biology of Sex Differences
Verified
Journal Article
Open access
PDF file
JLJacqueline R. Leachman
Jacqueline R. Leachman
KHKory Heier
Kory Heier
FLFeitong Lei
Feitong Lei
NANermin Ahmed
Nermin Ahmed
CDCarolina Dalmasso
Carolina Dalmasso
ALAnalia S. Loria
Analia S. Loria
Background: Adverse childhood experiences (ACEs) are an independent risk factor for chronic diseases, including type 2 diabetes, stroke and ischemic heart disease. However, the effect of ACEs considering sex and race are not often reported in cohorts showing multiracial composition, with power to evaluate effects on underrepresented populations. Aim: To determine how sex and race affected the association of combined and individual ACEs with metabolic health biomarkers in the Southern Community Cohort Study (2012–2015). Methods: Self-reported data were analyzed from ACE surveys performed during the second follow-up of a cohort comprised by over 60% of Black subjects and with an overall mean age of 60 years. Results: BMI steadily increased with cumulative ACEs among Black and White women, but remained relatively stable in White men with ≥ 4 ACEs. Contrary, Black men showed an inverse association between ACE and BMI. Secondary analysis of metabolic outcomes showed that physical abuse was correlated with a 4.85 cm increase in waist circumference in Black subjects. Total cholesterol increased among individuals with more than 4 ACEs. In addition, increases in HbA1c were associated with emotional and maternal abuse in Black women and sexual abuse in White women. Conclusions: BMI is strongly associated with cumulative ACEs in women regardless the race, while waist circumference is strongly associated with ACEs in Black individuals, which combined with reduced BMI may indicate increased central adiposity in Black men. Our study suggests that sex and race influence the contribution of certain ACEs to impair metabolic health.